七部门发布重磅文件 脑机接口产业发展突破有了“施工图”

Core Viewpoint - The joint implementation opinion from seven government departments aims to accelerate the development of the brain-computer interface (BCI) industry, focusing on breakthroughs in implantable devices and establishing a comprehensive industrial ecosystem by 2030 [1][2]. Group 1: Development Goals - By 2027, key technologies in the BCI field are expected to achieve breakthroughs, establishing an advanced technical, industrial, and standard system, with products reaching international advanced levels [2]. - The BCI industry is projected to grow significantly, creating 2 to 3 industrial clusters and fostering new scenarios, models, and business formats [2]. - By 2030, the innovation capability of the BCI industry is anticipated to be significantly enhanced, with the formation of a reliable industrial system and the cultivation of 2 to 3 globally influential leading enterprises [2]. Group 2: Product Development - The opinion emphasizes accelerating the research and development of implantable devices, including high-density neural recording sensors and ultra-low power implantable chips [3]. - It also calls for the innovation of non-implantable devices, promoting lightweight, high-speed, and low-power developments in products like adhesive, ear, and head-mounted interfaces [3]. - The development of auxiliary devices is encouraged, integrating brain signals with other physiological signals to improve interaction control and perception assessment accuracy [3]. Group 3: Policy Support and Market Impact - The opinion outlines the need for enhanced policy support, including increased investment from national funds and the implementation of a "technology-industry-finance integration" initiative [4]. - Recent measures have been introduced to support the registration and pricing of implantable BCI medical devices, with specific costs established for procedures [4]. - The successful clinical trial of an implantable BCI in China marks a significant milestone, positioning the country as the second globally to enter this phase after the United States [4]. Group 4: Industry Collaboration - Industry experts emphasize the importance of collaboration among technology developers, clinical institutions, capital, and government to foster the incubation and realization of research outcomes [6]. - Startups in the BCI field are advised to balance short-term survival needs with long-term innovation goals to maintain investment in core technology development [6].